Dia-X Bond Universal

K220804 · DiaDent Group International · KLE · Jun 15, 2022 · Dental

Device Facts

Record IDK220804
Device NameDia-X Bond Universal
ApplicantDiaDent Group International
Product CodeKLE · Dental
Decision DateJun 15, 2022
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 872.3200
Device ClassClass 2

Intended Use

- All direct restorations - All indirect restorations - Desensitizing/sealing of tooth - Intra-oral repairs

Device Story

Dia-X Bond Universal is a single-bottle, light-cured resin tooth bonding agent used by dental professionals in clinical settings. It functions as a universal adhesive capable of total, self, and selective etching. The device contains 10-methacryloyloxydecyl dihydrogen phosphate (MDP), which utilizes a hydrophobic carbon chain and hydrophilic phosphate group to permeate dentin and enamel, increasing bonding to hydroxyapatite. After application to the tooth surface, the solvent is volatilized and the material is photopolymerized. The output is a bonded interface between the tooth structure and the restorative material, facilitating direct and indirect restorations, tooth desensitization, and intra-oral repairs. The device is intended for prescription use only.

Clinical Evidence

No clinical data was collected or provided. Substantial equivalence is supported by bench testing, including film thickness, shear bond strength, sensitivity to ambient light, and occlusion of dentinal tubules, alongside biocompatibility testing per ISO 10993 series (genotoxicity, sensitization, irritation, systemic toxicity). Cytotoxicity testing was deemed not applicable due to the acidic nature of the 10-MDP monomer.

Technological Characteristics

Universal resin bonding agent; single-bottle system. Composition includes 10-MDP, HEMA, BisGMA/TEGDMA, and silicon dioxide. Principle: photopolymerization after solvent volatilization. Conforms to ISO 4049 (polymer-based restorative materials) and ISO 29022 (notched-edge shear bond strength). Biocompatibility evaluated per ISO 10993-1, 3, 5, 10, and 11. No software or electronic components.

Indications for Use

Indicated for all direct and indirect dental restorations, desensitizing or sealing of teeth, and intra-oral repairs in patients requiring dental adhesive procedures.

Regulatory Classification

Identification

A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is in blue and consists of the letters "FDA" followed by the words "U.S. FOOD & DRUG ADMINISTRATION". June 15, 2022 Diadent Group International Kab Lee Quality Assurance Manager 16, Osongsaengmyeong 4-ro, Osong-eup, Heungdeok-gu Cheongju-si, Chungcheongbuk-do 28161 SOUTH KOREA Re: K220804 Trade/Device Name: Dia-X Bond Universal Regulation Number: 21 CFR 872.3200 Regulation Name: Resin Tooth Bonding Agent Regulatory Class: Class II Product Code: KLE Dated: May 11, 2022 Received: May 16, 2022 Dear Kab Lee: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K220804 Device Name Dia-X Bond Universal Indications for Use (Describe) - All direct restorations - All indirect restorations - Desensitizing/sealing of tooth - Intra-oral repairs Type of Use (Select one or both, as applicable) X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) ## CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ## *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ # Diadent Group International # Special 510(k) Summary ## 1 Application Information | Date Prepared: | May 11, 2022 | |------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------| | Company Name and<br>Address: | DiaDent Group International<br>16, Osongsaengmyeong 4-ro, Osong-eup, Heungdeok-gu, Cheongju-<br>si, Chungcheongbuk-do, 28161, Republic of Korea | | Contact Person: | Kab Sun, Lee<br>Quality Assurance Manager<br>Phone: +82-43-266-2315<br>FAX: +82-43-235-2315<br>Email: diadent32@diadent.co.kr | #### 2 Device Information | 510(k) Number | K220804 | |---------------------|-----------------------------| | Classification Name | Agent, Tooth Bonding, Resin | | Common Name | Resin tooth bonding agent. | | Review Panel: | Dental | | Regulation Number: | 21 CFR 872.3200 | | Product Code: | KLE | | Device Class: | II | | Trade Name | Dia-X Bond Universal | #### 3 Predicate Devices The legally marketed devices to which substantial equivalence is being claimed are: | | Primary Predicate Device | |--------------------|-----------------------------| | 510(k) Number: | K213401 | | Applicant: | DiaDent Group International | | Device Name: | DIAPLUS Universal | | Regulation Number: | 21 CFR 872.3200 | | Product Code: | KLE | | Device Class: | II | ## 4 Device Configuration Dia-X Bond Universal: 1 bottle (5ml, 1ml) # 5 Device Description Dia-X Bond Universal is a universal adhesive capable of total, self, and selective etching as it consists of a single bottle of etching, primer, and adhesive resin. It can be used for both direct bonding of restorations. ## 6 Intended Use/Indications for Use - All direct restorations - All indirect restorations - Desensitizing/sealing of tooth - Intra-oral repairs {4}------------------------------------------------ # Diadent Group International # 7 Comparison Table and Discussion This device compares to the legally marketed devices as follows: | | Subject Device | Primary Predicate Device | | |----------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------| | Common name | Resin tooth bonding agent. | Resin tooth bonding agent. | | | Trade Name | Dia-X Bond Universal | DIAPLUS Universal | Discussion | | 510(k)<br>Number | K220804 | K213401 | | | Indication for<br>Use | - All direct restorations<br>- All indirect restorations<br>- Desensitizing/sealing of tooth<br>- Intra-oral repairs | - All direct restorations<br>- All indirect restorations<br>- Desensitizing/sealing of tooth<br>- Intra-oral repairs | Equivalent | | Composition | - 10-methacryloyloxydecyl<br>dihydrogenphosphate<br>- 2-Hydroxyethyl methacryalate<br>- Bis[2-(methacryloyloxy)ethyl]<br>phosphate<br>- 3-(Trimethoxysilyl)propyl<br>methacrylate<br>- Trimethylolpropane trimethacrylate<br>- BisGMA/TEGDMA Monomer Blend<br>- Poly(ethylene glycol) dimethacrylate<br>- Diphenyliodonium<br>hexafluorophosphate<br>- Phenyl Bis(2,4,6-<br>Trimethylbenzoyl)phosphineoxide<br>- (+/-)Camphorquinone<br>- Ethyl 4-dimethyl aminobenzoate<br>- tert-butyl hydroquinone<br>- Ethyl alcohol<br>- Silicon dioxide | - 10-methacryloyloxydecyl<br>dihydrogenphosphate<br>- 2-Hydroxyethyl methacryalate<br>- Bis[2-(methacryloyloxy)ethyl]<br>phosphate<br>- 3-(Trimethoxysilyl)propyl<br>methacrylate<br>- Trimethylolpropane trimethacrylate<br>- BisGMA/TEGDMA Monomer Blend<br>- Poly(ethylene glycol) dimethacrylate<br>- Diphenyliodonium<br>hexafluorophosphate<br>- Phenyl Bis(2,4,6-<br>Trimethylbenzoyl)phosphineoxide<br>- (+/-)Camphorquinone<br>- Ethyl 4-dimethyl aminobenzoate<br>- tert-butyl hydroquinone<br>- Ethyl alcohol<br>- Silicon dioxide | Equivalent | | Principle of<br>operation | After being applied to the tooth<br>surface, the solvent is volatilized and<br>photopolymerized in the drying<br>process to perform the function as a<br>dentin adhesive. The main material,<br>MDP contains a hydrophobic long<br>carbon chain and a hydrophilic<br>phosphate group, so it has excellent<br>surface activity and can easily<br>permeates dentin & enamel. It<br>increases bonding to hydroxyapatite<br>remaining in dentin. | After being applied to the tooth<br>surface, the solvent is volatilized and<br>photopolymerized in the drying<br>process to perform the function as a<br>dentin adhesive. The main material,<br>MDP contains a hydrophobic long<br>carbon chain and a hydrophilic<br>phosphate group, so it has excellent<br>surface activity and can easily<br>permeates dentin & enamel. It<br>increases bonding to hydroxyapatite<br>remaining in dentin. | Equivalent | | Performance<br>Standard<br>Conformance | Conformed<br>ISO 4049 and ISO 29022 | Conformed<br>ISO 4049 and ISO 29022 | Equivalent | | Physical<br>properties | - Film thickness<br>- Sensitivity to light<br>- Shear bond strength<br>- Occlusion of dental tubules | - Film thickness<br>- Sensitivity to light<br>- Shear bond strength<br>- Occlusion of dental tubules | Equivalent | | Biocompatibil<br>ity | Biocompatible | Biocompatible | Equivalent | | Package<br>Contents | One bottle | One bottle | Equivalent | | RX only/<br>OTC | RX Only | RX Only | Equivalent | {5}------------------------------------------------ # 8 Non-Clinical performance data This device has demonstrated conformance with non-clinical performance requirements through evaluation and testing in accordance with the following harmonized standards: | -ISO 4049 | Dentistry -- Polymer-based restorative materials | |---------------|------------------------------------------------------------------------------------------------------------------------| | -ISO 7405 | Dentistry - Evaluation of Biocompatibility of Medical Devices Used In Dentistry<br>[Including: Amendment 1 (2013)] | | -ISO 29022 | Dentistry - Adhesive - Notched-edge sheer bond strength test | | -ISO 10993-1 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a<br>risk management process | | -ISO 10993-3 | Biological evaluation of medical devices - Part 3: Tests for genotoxicity<br>carcinogenicity and reproductive toxicity | | -ISO 10993-5 | Biological evaluation of medical devices - Part 5: Tests for in vitro Cytotoxicity | | -ISO 10993-10 | Biological evaluation of medical devices - Part 10: Tests for irritation and skin<br>sensitization | | -ISO 10993-11 | Biological evaluation of medical devices - Part 11: Tests for Systemic toxicity | The following Performance tests were conducted. - Film Thickness - Shear Bonding Strength - Sensitivity to Ambient Light - Occlusion of dentinal tubules Biocompatibility test: | Test | Standard | Test result | |------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|--------------------------| | Cytotoxicity Study | •10993-5 - Biological Evaluation of Medical Devices -<br>Part 5: Tests for In Vitro Cytotoxicity | Not<br>Compatible<br>BSE | | Bacterial Reverse<br>Mutation Study | •10993-3 - Biological Evaluation of Medical Devices -<br>Part 3: Tests for genotoxicity, carcinogenicity and<br>reproductive toxicity | Compatible | | In vitro Mammalian<br>Chromosomal<br>Aberration Test | •10993-3 - Biological Evaluation of Medical Devices -<br>Part 3: Tests for genotoxicity, carcinogenicity and<br>reproductive toxicity | Compatible | | Mammalian<br>Erythrocyte<br>Micronucleus | •10993-3 - Biological Evaluation of Medical Devices -<br>Part 3: Tests for genotoxicity, carcinogenicity and<br>reproductive toxicity | Compatible | | Skin Sensitization<br>Test | •10993-10 - Biological Evaluation of Medical Devices -<br>Part 10: Tests for Irritation and Skin Sensitization | Compatible | | Oral Mucosa<br>Irritation Test | •10993-10 - Biological Evaluation of Medical Devices -<br>Part 10: Tests for Irritation and Skin Sensitization | Compatible | | Acute Systemic<br>Toxicity | •10993-11 - Biological Evaluation of Medical Devices -<br>Part 11: Tests for Systemic Toxicity | Compatible | {6}------------------------------------------------ #### Diadent Group International (Among the components of this product, 10-MDP is an acidic monomer, and depending on the acidity, it is a substance that causes cytotoxicity according to the principle of action of this product, so cytotoxicity test setting the test item is meaningless. #### 9 Clinical Performance Data No clinical data was collected or provided to support substantial equivalence between the subject and predicate devices. #### 10. Conclusion Based on the above information and all data provided in this submission, the comparison of intended uses, technological characteristics, and non-clinical performance testing demonstrates that the subject device is substantially equivalent to the legally marketed devices identified in this submission.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%